Ollivier Hyrien - Concepedia

Author

Ollivier Hyrien

University of Rochester Medical Center ORCID

Also Known As

Cohen, M.S., Hyrien, Ollivier, Koup, Richard A., O Hyrien, O. HYRIEN, O. Hyrien, OLLIVIER HYRIEN, Ollivier Hyrien, Ollivier Hyrien (565498), Piwowar-Manning, Estelle

158

Publications

3.2K

Citations

H-Index

147

Concepts

All Affiliations

University of Rochester Medical Center Fred Hutch Cancer Center University of Washington University of Rochester National Institute of Allergy and Infectious Diseases

About

Ollivier Hyrien is an author at University of Rochester Medical Center specializing in medicine, radiation oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.3K
2	Engineering	8	8	201
3	Health Sciences	5	5	277
4	Language Studies	1	1	27
5	Public Health	1	1	114

Ollivier Hyrien

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
The Spectrum of Neurobehavioral Sequelae after Repetitive Mild Traumatic Brain Injury: A Novel Mouse Model of Chronic Traumatic Encephalopathy Anthony L. Petraglia, Benjamin A. Plog, Samantha Dayawansa, Journal of Neurotrauma Traumatic Brain InjuryNeuropsychologyRepetitive Mtbi MiceChronic Traumatic EncephalopathyNeurological Injury	2014	217
Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma Gregory C. Connolly, Rui Chen, Ollivier Hyrien, Thrombosis Research HepatologyMedicinePathologyCirrhosisComplications Of Cirrhosis	2007	155
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab Shannon P. Hilchey, Ollivier Hyrien, Tim R. Mosmann, Blood	2009	153
The pathophysiology underlying repetitive mild traumatic brain injury in a novel mouse model of chronic traumatic encephalopathy Anthony L. Petraglia, Benjamin A. Plog, Samantha Dayawansa, Surgical Neurology International	2014	143
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials Devan V. Mehrotra, Holly Janes, Thomas R. Fleming, Annals of Internal Medicine VaccinationSeveral Vaccine CandidatesMedicineVaccine TargetCovid-19 Pandemic	2020	114
Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitis Yuhchyau Chen, Ollivier Hyrien, Jacqueline P. Williams, International Journal of Radiation OncologyBiologyPhysics InflammationCytokineImmunologyInflammatory MarkerAutoimmunity	2005	96
Pig-a Mutation: Kinetics in Rat Erythrocytes Following Exposure to Five Prototypical Mutagens Souk Phonethepswath, Dean Franklin, Dorothea K. Torous, Toxicological Sciences	2009	92
Integration of Mutation and Chromosomal Damage Endpoints into 28-Day Repeat Dose Toxicology Studies Stephen D. Dertinger, Souk Phonethepswath, Dean Franklin, Toxicological Sciences	2010	91
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial Youyi Fong, Adrian B. McDermott, David Benkeser, Nature Microbiology VaccinationVaccine DevelopmentImmunologyVaccine EfficacyMedicine	2022	89
Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness Shannon P. Hilchey, James J. Kobie, Mathew R. Cochran, The Journal of Immunology	2009	78

Page 1